Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Investors also seek greater clarity whether the company can deliver on its fourth-quarter revenue guidance, Risinger added
Long-term use of medications that affect bone metabolismincluding corticosteroids, proton pump inhibitors, anticonvulsants, or aromatase inhibitorsalso increases bone health risks
Brigger D, Guntern P, Pennington LF, van Brummelen R, Jardetzky TS, Eggel A (2025) High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo
PubMed laboratory research record [PMID: 10613367] PubMed record related to this compound for laboratory literature review
US$ 25.36
US$ 20.71
US$ 22.51
US$ 22.31
US$ 21.33
US$ 21.43
US$ 29.92
